Crizotinib as a personalized alternative for targeted anaplastic lymphoma kinase rearrangement in previously treated patients with non-small-cell lung cancer
about
Crizotinib as a personalized alternative for targeted anaplastic lymphoma kinase rearrangement in previously treated patients with non-small-cell lung cancer
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Crizotinib as a personalized a ...... ith non-small-cell lung cancer
@ast
Crizotinib as a personalized a ...... ith non-small-cell lung cancer
@en
Crizotinib as a personalized a ...... ith non-small-cell lung cancer
@nl
type
label
Crizotinib as a personalized a ...... ith non-small-cell lung cancer
@ast
Crizotinib as a personalized a ...... ith non-small-cell lung cancer
@en
Crizotinib as a personalized a ...... ith non-small-cell lung cancer
@nl
prefLabel
Crizotinib as a personalized a ...... ith non-small-cell lung cancer
@ast
Crizotinib as a personalized a ...... ith non-small-cell lung cancer
@en
Crizotinib as a personalized a ...... ith non-small-cell lung cancer
@nl
P2093
P2860
P921
P356
P1476
Crizotinib as a personalized a ...... ith non-small-cell lung cancer
@en
P2093
Baoan Chen
Haijun Zhang
Liting Guo
Weiwei Shao
P2860
P304
P356
10.2147/DDDT.S91988
P407
P5008
P577
2015-10-03T00:00:00Z